Andrew Ustianowski

22.2k citations

77 papers · 3.5k indexed · 3 hit papers · h-index 22

Impact in

Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research

Papers in

Hepatology 22
- Hepatitis C virus research 18
- Hepatitis Viruses Studies and Epidemiology 7
Infectious Diseases 40
- HIV/AIDS Research and Interventions 13
- SARS-CoV-2 and COVID-19 Research 8
- HIV/AIDS drug development and treatment 8

Co-authors: Rosanna Ŵ. Peeling Mark D. Perkins David Mabey James Galloway Kath Watson Mark Lunt William G Dixon Kimme L Hyrich
Journals: Infectious Diseases and Therapy (6 papers)Journal of Hepatology (4 papers)HIV Medicine (3 papers)Annals of the Rheumatic Diseases (3 papers)Open Forum Infectious Diseases (3 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Andrew Ustianowski

76 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly 2010 · 496 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Lara D. Veeken
2009 Annals of the Rheumatic Diseases
2004 Nature Reviews Microbiology

Peers

Countries citing papers authored by Andrew Ustianowski

Since Specialization

Citations

This map shows the geographic impact of Andrew Ustianowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Ustianowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Ustianowski more than expected).

Fields of papers citing papers by Andrew Ustianowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Ustianowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Ustianowski. The network helps show where Andrew Ustianowski may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrew Ustianowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrew Ustianowski Line = papers co-authored together Andrew Ustianowski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom HIV Medicine ·Stephanie Q Ko, Lourdes Domínguez, Min-Jhan Li, Lucy Campbell, Julie Fox, Fiona Burns, Lisa Hamzah, Andrew Ustianowski, Amanda Clarke, Stephen Kegg, 千賀高羽, Rachael Jones, Sarah Pett, Синельникова Ольга Викторовна, Frank A. Post	2024	1
2	Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients Clinical Therapeutics ·Essy Mozaffari, Aastha Chandak, Andrew Ustianowski, Christina G. Rivera, Neera Ahuja, E.Yu. Pustova, Mark Berry, Jason F. Okulicz, Alpesh Amin	2024	1
3	Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster Campaigns Infectious Diseases and Therapy ·Diana Mendes, G. Antoniuk, Hj. Nurleli, Thomas Padgett, Deivid Ismael Kern, W. David Strain, Andrea Manca, Andrew Ustianowski, Chunfang Zhang, Elizabeth Hamson, Charles Reynard, Jingyan Yang	2024	2
4	Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials Infectious Diseases and Therapy ·Myron J. Levin, Andrew Ustianowski, Stéphane De Wit, Huffman, Rizky Pasca Baisary, Jorge Oswaldo López Velasquez, Edgardo Enrique Llerena Henzler, Carlos E. Caicedo, Katie Streicher, Alexandre Kiazand, Mark T. Esser	2024	0
5	Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study JHEP Reports ·Marianne Martinello, Sanjay Bhagani, David Shaw, Chloe Orkin, Graham Cooke, Edward Gane, David Iser, Andrew Ustianowski, Ranjababu Kulasegaram, Catherine Stedman, Elise Tu, Jason Grebely, Gregory J. Dore, Mark Nelson, Gail Matthews	2023	4
6	Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy Clinics and Research in Hepatology and Gastroenterology ·Jeffrey V. Lazarus, Camila A Picchio, Kaihuan Yu, Soo Aleman, Hornady Gj, Felice Nava, Anne Øvrehus, Juan Turnés, John W. Ward, Andrew Ustianowski	2021	13
7	Impact of direct‐acting antiviral agents on liver function in patients with chronic hepatitis C virus infection Journal of Viral Hepatitis ·Philip J. Johnson, Sarah Berhane, Alex J Walker, F. Gordon, Stephen Ryder, Stuart McPherson, Aravamuthan Sreedharan, Andrew Ustianowski, Kosh Agarwal, David Mutimer, Gu XB, Hidenori Toyoda, William L. Irving	2020	7
8	Assessment of fever in the returning traveller British Journal of Hospital Medicine ·Restu Novi Sari Sudjarwo, Andrew Ustianowski, Yesica Gisel Candia	2018	1
9	HIV, HCV and HBV: A Review of Parallels and Differences Infectious Diseases and Therapy ·B. Wahlen, Andrew Ustianowski, Yesica Gisel Candia, Joop E. Arends	2018	24
10	Short Communication: Diagnosis of Pneumocystis jirovecii Pneumonia by Detection of DNA in Blood and Oropharyngeal Wash, Compared with Sputum AIDS Research and Human Retroviruses ·艾和才, J. Ma, Joanne Baxter, Sam Douthwaite, D. E. Wallace, Malcolm Guiver, Andrew Ustianowski	2016	13
11	Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia Journal of NeuroVirology ·Sam Nightingale, Anna María Geretti, Apostolos Beloukas, Martin Fisher, Alan Winston, Laura Else, Mark Nelson, Stephen Taylor, Andrew Ustianowski, Jonathan Ainsworth, Richard Gilson, Lewis Haddow, Edmund Ong, Victoria Watson, Clifford Leen, Jane Minton, Frank A. Post, Munir Pirmohamed, Tom Solomon, Saye Khoo	2016	41
12	CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF Cytokine ·Sam Nightingale, Benedict Michael, Martin Fisher, Alan Winston, Mark Nelson, Stephen Taylor, Andrew Ustianowski, Jonathan Ainsworth, Richard Gilson, Lewis Haddow, Edmund Ong, Clifford Leen, Jane Minton, Frank A. Post, Apostolos Beloukas, Ray Borrow, Munir Pirmohamed, Anna María Geretti, Saye Khoo, Tom Solomon	2016	20
13	Zika virus: management of infection and risk BMJ ·Shazaad Ahmad, He Chen Zhu, Andrew Ustianowski	2016	16
14	Review article: 2014 UK consensus guidelines – hepatitis C management and direct‐acting anti‐viral therapy Alimentary Pharmacology & Therapeutics ·Michael H. Miller, Kosh Agarwal, Lucien Faugères, Ashley Brown, Stephen T. Barclay, Wenshuang Liao, Geoffrey Dusheiko, Graham R. Foster, Ray Fox, Peter Hayes, Clifford Leen, Patrick van Kleef, Stephen Ryder, Peter Vermeersch, Andrew Ustianowski, John Dillon	2014	31
15	Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register Annals of the Rheumatic Diseases ·James Galloway, Kimme L Hyrich, Louise Mercer, William G Dixon, Andrew Ustianowski, MATTHEW HELBERT, Kath Watson, Mark Lunt, Deborah Symmons	2011	145
16	Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly Lara D. Veeken ·James Galloway, Kimme L Hyrich, Louise Mercer, William G Dixon, Bo Fu, Andrew Ustianowski, Kath Watson, Mark Lunt, Deborah Symmons, (unknown) Hit paper breakdown →	2010	496
17	Malaria: an update on treatment of adults in non-endemic countries BMJ ·C. W. M. Whitty, David G. Lalloo, Andrew Ustianowski	2006	13
18	Human Immunodeficiency Virus Type 1-Related Pulmonary Mycobacterium xenopi Infection: A Need to Treat? Clinical Infectious Diseases ·Christopher Nørgaard Bach, Andrew Ustianowski, Margaret Johnson, Stephen H. Gillespie, Robert F. Miller, Marc Lipman	2003	11
19	M. tuberculosis: immunology and vaccination European Respiratory Journal ·G.A.W. Rook, Andrew Ustianowski	2001	39
20	HIV-1 Seroprevalence in Zambian Patients With Acute Diarrhea: A Community-Based Study Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·K S Baboo, N. Luo, James R. Murphy, Veronica González Molina, Chifumbe Chintu, Andrew Ustianowski, Herbert L. DuPont, Ananda Olivia, John J. Mathewson, Alimuddin Zumla	1999	3

About Andrew Ustianowski

Andrew Ustianowski is a scholar working on Hepatology, Infectious Diseases, Virology, Epidemiology and Emergency Medicine, having authored 77 papers that have together received 3.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (18 papers), HIV/AIDS Research and Interventions (13 papers), Liver Disease Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (11 papers), HIV Research and Treatment (9 papers), SARS-CoV-2 and COVID-19 Research (8 papers), HIV/AIDS drug development and treatment (8 papers) and Hepatitis Viruses Studies and Epidemiology (7 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Rheumatology (787 citations), Hepatology (332 citations), Hematology (359 citations) and Virology (150 citations). Andrew Ustianowski has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Rosanna Ŵ. Peeling, Mark D. Perkins, David Mabey, James Galloway, Kath Watson, Mark Lunt, William G Dixon, Kimme L Hyrich, Deborah Symmons and Louise Mercer. Their work appears in journals such as Infectious Diseases and Therapy, Journal of Hepatology, HIV Medicine, Annals of the Rheumatic Diseases and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact